Invention Grant
US07988973B2 Activin-ActRII antagonists and uses for increasing red blood cell levels
有权
Activin-ActRII拮抗剂和用于增加红细胞水平的用途
- Patent Title: Activin-ActRII antagonists and uses for increasing red blood cell levels
- Patent Title (中): Activin-ActRII拮抗剂和用于增加红细胞水平的用途
-
Application No.: US12002872Application Date: 2007-12-18
-
Publication No.: US07988973B2Publication Date: 2011-08-02
- Inventor: Matthew L. Sherman
- Applicant: Matthew L. Sherman
- Applicant Address: US MA Cambridge
- Assignee: Acceleron Pharma Inc.
- Current Assignee: Acceleron Pharma Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Ropes & Gray LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/00
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Public/Granted literature
- US20090047281A1 Activin-ActRII antagonists and uses for increasing red blood cell levels Public/Granted day:2009-02-19
Information query
